Intracranial Therapeutic Market, Global Outlook and Forecast 2022-2028

August 2022 | 68 pages | ID: I093FA499EF6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Intracranial Therapeutic in Global, including the following market information:

Global Intracranial Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Intracranial Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cell-based Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intracranial Therapeutic include Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, Inc., Apic Bio, Stemedica Cell Technologies, Inc., Voyager Therapeutics, Bayer AG and Abeona Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intracranial Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intracranial Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Intracranial Therapeutic Market Segment Percentages, by Type, 2021 (%)

• Cell-based Therapy
• Gene Therapy
• Enzyme Replacement Therapy

Global Intracranial Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Intracranial Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Spinal Muscular Atrophy (SMA)
• Multiple Sclerosis
• Batten Disease
• Amyotrophic Lateral Sclerosis

Global Intracranial Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Intracranial Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intracranial Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Intracranial Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• BioMarin
• CORESTEM Inc.
• Alaunos Therapeutics, Inc.
• Apic Bio
• Stemedica Cell Technologies, Inc.
• Voyager Therapeutics
• Bayer AG
• Abeona Therapeutics
• Spark Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Intracranial Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Intracranial Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTRACRANIAL THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Intracranial Therapeutic Market Size: 2021 VS 2028
2.2 Global Intracranial Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Intracranial Therapeutic Players in Global Market
3.2 Top Global Intracranial Therapeutic Companies Ranked by Revenue
3.3 Global Intracranial Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Intracranial Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Intracranial Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intracranial Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Intracranial Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Intracranial Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Intracranial Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Cell-based Therapy
  4.1.3 Gene Therapy
  4.1.4 Enzyme Replacement Therapy
4.2 By Type - Global Intracranial Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Intracranial Therapeutic Revenue, 2017-2022
  4.2.2 By Type - Global Intracranial Therapeutic Revenue, 2023-2028
  4.2.3 By Type - Global Intracranial Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Intracranial Therapeutic Market Size, 2021 & 2028
  5.1.2 Spinal Muscular Atrophy (SMA)
  5.1.3 Multiple Sclerosis
  5.1.4 Batten Disease
  5.1.5 Amyotrophic Lateral Sclerosis
5.2 By Application - Global Intracranial Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Intracranial Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Intracranial Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Intracranial Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Intracranial Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Intracranial Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Intracranial Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Intracranial Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Intracranial Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Intracranial Therapeutic Revenue, 2017-2028
  6.3.2 US Intracranial Therapeutic Market Size, 2017-2028
  6.3.3 Canada Intracranial Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Intracranial Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Intracranial Therapeutic Revenue, 2017-2028
  6.4.2 Germany Intracranial Therapeutic Market Size, 2017-2028
  6.4.3 France Intracranial Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Intracranial Therapeutic Market Size, 2017-2028
  6.4.5 Italy Intracranial Therapeutic Market Size, 2017-2028
  6.4.6 Russia Intracranial Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Intracranial Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Intracranial Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Intracranial Therapeutic Revenue, 2017-2028
  6.5.2 China Intracranial Therapeutic Market Size, 2017-2028
  6.5.3 Japan Intracranial Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Intracranial Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Intracranial Therapeutic Market Size, 2017-2028
  6.5.6 India Intracranial Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Intracranial Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Intracranial Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Intracranial Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Intracranial Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Intracranial Therapeutic Market Size, 2017-2028
  6.7.3 Israel Intracranial Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Intracranial Therapeutic Market Size, 2017-2028
  6.7.5 UAE Intracranial Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Corporate Summary
  7.1.2 Novartis AG Business Overview
  7.1.3 Novartis AG Intracranial Therapeutic Major Product Offerings
  7.1.4 Novartis AG Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 Novartis AG Key News
7.2 BioMarin
  7.2.1 BioMarin Corporate Summary
  7.2.2 BioMarin Business Overview
  7.2.3 BioMarin Intracranial Therapeutic Major Product Offerings
  7.2.4 BioMarin Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 BioMarin Key News
7.3 CORESTEM Inc.
  7.3.1 CORESTEM Inc. Corporate Summary
  7.3.2 CORESTEM Inc. Business Overview
  7.3.3 CORESTEM Inc. Intracranial Therapeutic Major Product Offerings
  7.3.4 CORESTEM Inc. Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 CORESTEM Inc. Key News
7.4 Alaunos Therapeutics, Inc.
  7.4.1 Alaunos Therapeutics, Inc. Corporate Summary
  7.4.2 Alaunos Therapeutics, Inc. Business Overview
  7.4.3 Alaunos Therapeutics, Inc. Intracranial Therapeutic Major Product Offerings
  7.4.4 Alaunos Therapeutics, Inc. Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 Alaunos Therapeutics, Inc. Key News
7.5 Apic Bio
  7.5.1 Apic Bio Corporate Summary
  7.5.2 Apic Bio Business Overview
  7.5.3 Apic Bio Intracranial Therapeutic Major Product Offerings
  7.5.4 Apic Bio Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 Apic Bio Key News
7.6 Stemedica Cell Technologies, Inc.
  7.6.1 Stemedica Cell Technologies, Inc. Corporate Summary
  7.6.2 Stemedica Cell Technologies, Inc. Business Overview
  7.6.3 Stemedica Cell Technologies, Inc. Intracranial Therapeutic Major Product Offerings
  7.6.4 Stemedica Cell Technologies, Inc. Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 Stemedica Cell Technologies, Inc. Key News
7.7 Voyager Therapeutics
  7.7.1 Voyager Therapeutics Corporate Summary
  7.7.2 Voyager Therapeutics Business Overview
  7.7.3 Voyager Therapeutics Intracranial Therapeutic Major Product Offerings
  7.7.4 Voyager Therapeutics Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.7.5 Voyager Therapeutics Key News
7.8 Bayer AG
  7.8.1 Bayer AG Corporate Summary
  7.8.2 Bayer AG Business Overview
  7.8.3 Bayer AG Intracranial Therapeutic Major Product Offerings
  7.8.4 Bayer AG Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.8.5 Bayer AG Key News
7.9 Abeona Therapeutics
  7.9.1 Abeona Therapeutics Corporate Summary
  7.9.2 Abeona Therapeutics Business Overview
  7.9.3 Abeona Therapeutics Intracranial Therapeutic Major Product Offerings
  7.9.4 Abeona Therapeutics Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.9.5 Abeona Therapeutics Key News
7.10 Spark Therapeutics
  7.10.1 Spark Therapeutics Corporate Summary
  7.10.2 Spark Therapeutics Business Overview
  7.10.3 Spark Therapeutics Intracranial Therapeutic Major Product Offerings
  7.10.4 Spark Therapeutics Intracranial Therapeutic Revenue in Global Market (2017-2022)
  7.10.5 Spark Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Intracranial Therapeutic Market Opportunities & Trends in Global Market
Table 2. Intracranial Therapeutic Market Drivers in Global Market
Table 3. Intracranial Therapeutic Market Restraints in Global Market
Table 4. Key Players of Intracranial Therapeutic in Global Market
Table 5. Top Intracranial Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Intracranial Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Intracranial Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Intracranial Therapeutic Product Type
Table 9. List of Global Tier 1 Intracranial Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intracranial Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Intracranial Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Intracranial Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Intracranial Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Intracranial Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Intracranial Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Intracranial Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Intracranial Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Intracranial Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Intracranial Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Intracranial Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Intracranial Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Intracranial Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Intracranial Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Intracranial Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Intracranial Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Intracranial Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Intracranial Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Intracranial Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Intracranial Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Intracranial Therapeutic Product Offerings
Table 32. Novartis AG Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. BioMarin Corporate Summary
Table 34. BioMarin Intracranial Therapeutic Product Offerings
Table 35. BioMarin Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. CORESTEM Inc. Corporate Summary
Table 37. CORESTEM Inc. Intracranial Therapeutic Product Offerings
Table 38. CORESTEM Inc. Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Alaunos Therapeutics, Inc. Corporate Summary
Table 40. Alaunos Therapeutics, Inc. Intracranial Therapeutic Product Offerings
Table 41. Alaunos Therapeutics, Inc. Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Apic Bio Corporate Summary
Table 43. Apic Bio Intracranial Therapeutic Product Offerings
Table 44. Apic Bio Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Stemedica Cell Technologies, Inc. Corporate Summary
Table 46. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Product Offerings
Table 47. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. Voyager Therapeutics Corporate Summary
Table 49. Voyager Therapeutics Intracranial Therapeutic Product Offerings
Table 50. Voyager Therapeutics Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Bayer AG Corporate Summary
Table 52. Bayer AG Intracranial Therapeutic Product Offerings
Table 53. Bayer AG Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. Abeona Therapeutics Corporate Summary
Table 55. Abeona Therapeutics Intracranial Therapeutic Product Offerings
Table 56. Abeona Therapeutics Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)
Table 57. Spark Therapeutics Corporate Summary
Table 58. Spark Therapeutics Intracranial Therapeutic Product Offerings
Table 59. Spark Therapeutics Intracranial Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Intracranial Therapeutic Segment by Type in 2021
Figure 2. Intracranial Therapeutic Segment by Application in 2021
Figure 3. Global Intracranial Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Intracranial Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Intracranial Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intracranial Therapeutic Revenue in 2021
Figure 8. By Type - Global Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Intracranial Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Intracranial Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioMarin Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. CORESTEM Inc. Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alaunos Therapeutics, Inc. Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Apic Bio Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Voyager Therapeutics Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer AG Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abeona Therapeutics Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Spark Therapeutics Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)